We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 52.03%
This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+52.03%
3 Year Est. Return
+131.18%
5 Year Est. Return
+187.67%
10 Year Est. Return
+1,140.82%
AUM
$627M
AUM Growth
-$205M
Cap. Flow
+$37.7M
Cap. Flow %
6%
Top 10 Hldgs %
25.67%
Holding
102
New
6
Increased
38
Reduced
34
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$15.4M
2
HUM icon
Humana
HUM
+$14.8M
3
PFE icon
Pfizer
PFE
+$14.2M
4
MCK icon
McKesson
MCK
+$11M
5
AMGN icon
Amgen
AMGN
+$10.4M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$18.6M
3
UNH icon
UnitedHealth
UNH
+$10.1M
4
RAD
Rite Aid Corporation
RAD
+$9.6M
5
CVS icon
CVS Health
CVS
+$9.15M

Sector Composition

Rank Sector Weight
1 Healthcare 95.45%
2 Financials 2.41%
3 Miscellaneous 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1
Amgen
AMGN
$206B
$18.7M 2.98%
135,000
+66,000
+96% +$10.4M
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$18M 2.87%
115,000
-17,800
-13% -$3.25M
MDT icon
3
Medtronic
MDT
$119B
$17.7M 2.83%
265,000
+110,200
+71% +$8.12M
UNH icon
4
UnitedHealth
UNH
$340B
$17.1M 2.72%
147,000
-84,000
-36% -$10.1M
LLY icon
5
Eli Lilly
LLY
$1.02T
$15.5M 2.47%
185,000
+10,000
+6% +$844K
AET
6
DELISTED
Aetna Inc
AET
$15.1M 2.41%
138,000
+87,000
+171% +$10.1M
ELV icon
7
Elevance Health
ELV
$89.9B
$15M 2.39%
107,000
+49,000
+84% +$7.36M
ALKS icon
8
Alkermes
ALKS
$7.83B
$15M 2.39%
255,000
-94,000
-27% -$6.21M
CELG
9
DELISTED
Celgene Corp
CELG
$14.7M 2.35%
136,000
-1,000
-0.7% -$124K
HUM icon
10
Humana
HUM
$46.5B
$14.3M 2.28%
+80,000
New +$14.8M
CI icon
11
Cigna
CI
$73.4B
$14.3M 2.28%
+105,900
New +$15.4M
MCK icon
12
McKesson
MCK
$103B
$14.2M 2.27%
77,000
+52,000
+208% +$11M
HCA icon
13
HCA Healthcare
HCA
$93.4B
$13.9M 2.22%
180,000
+111,000
+161% +$9.83M
PFE icon
14
Pfizer
PFE
$157B
$13.2M 2.11%
+443,734
New +$14.2M
AGN
15
DELISTED
Allergan plc
AGN
$12.5M 1.99%
46,000
+4,000
+10% +$1.23M
CAH icon
16
Cardinal Health
CAH
$53B
$12.2M 1.95%
159,000
-56,000
-26% -$4.68M
BDX icon
17
Becton Dickinson
BDX
$50B
$12.1M 1.92%
93,275
+31,775
+52% +$4.44M
INCY icon
18
Incyte
INCY
$25.5B
$12M 1.92%
109,000
+1,498
+1% +$168K
STJ
19
DELISTED
St Jude Medical
STJ
$12M 1.91%
190,000
+107,000
+129% +$7.64M
ABBV icon
20
AbbVie
ABBV
$463B
$11.4M 1.82%
210,000
-23,000
-10% -$1.5M
BMY icon
21
Bristol-Myers Squibb
BMY
$129B
$11.4M 1.81%
192,000
-6,000
-3% -$381K
GILD icon
22
Gilead Sciences
GILD
$185B
$11.3M 1.8%
115,000
-15,000
-12% -$1.67M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$130B
$10.9M 1.74%
105,000
+50,000
+91% +$6.42M
PRGO icon
24
Perrigo
PRGO
$1.86B
$10.2M 1.63%
65,000
+18,000
+38% +$3.3M
CNC icon
25
Centene
CNC
$33.2B
$9.49M 1.51%
350,000
+242,000
+224% +$8.1M
1
2 3 4 5

Similar funds

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
PCI
Planning Center Inc Moline, Illinois $1.06B AUM 12.82% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
BDP
Brehaut David Pascal $1.06B AUM
GX
Greylock XIV Menlo Park, California $1.06B AUM
CIC
Cutler Investment Counsel Jacksonville, Oregon $1.06B AUM 20.29% 1-Year Est. Return
RCIM
Red Cedar Investment Management Grand Rapids, Michigan $1.06B AUM 30.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Rhenman & Partners Asset Management held 102 positions worth $627M, down 25% from $833M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rhenman & Partners Asset Management deployed $37.7M of net new capital in Q3 2015, opening 6 new positions and adding to 38 existing holdings. Its largest new stake was Cigna: 105,900 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 81% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was UnitedHealth, an estimated $10.1M trimmed.

  • Rhenman & Partners Asset Management's largest Q3 2015 buy was Cigna: 105,900 shares worth $14.3M.
  • Rhenman & Partners Asset Management added most to McKesson in Q3 2015, an estimated $11M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2015 reduction was UnitedHealth, cutting an estimated $10.1M.
  • Rhenman & Partners Asset Management fully exited Biogen in Q3 2015, selling an estimated $20.3M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 26% of its $627M portfolio in Q3 2015.
  • Rhenman & Partners Asset Management opened 6 new positions and closed 11 in Q3 2015.
  • Rhenman & Partners Asset Management's portfolio value fell 25% quarter-over-quarter to $627M.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2015, filed 26 Oct 2015.